Publication:
Contribution of Comorbidities in Mortality of COVID-19 Patients Admitted to Tertiary Care Center: A Descriptive Cross-sectional Study

creativeworkseries.issnISSN (Print) : 1993-2979 | ISSN (Online) : 1993-2987
dc.contributor.authorBhandari, Nirajan
dc.contributor.authorKC, Rupak
dc.contributor.authorPaudel, Neetika
dc.contributor.authorChaulagain, Pratima
dc.contributor.authorSingh, Pankaj Kumar
dc.contributor.authorPandey, Ravi
dc.date.accessioned2025-11-09T04:39:02Z
dc.date.available2025-11-09T04:39:02Z
dc.date.issued2024
dc.descriptionNirajan Bhandari Nepalgunj Medical College and Teaching Hospital, Nepalgunj, Banke, Nepal Author Rupak KC Nepalgunj Medical College and Teaching Hospital, Nepalgunj, Banke, Nepal Author Neetika Paudel Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal Author Pratima Chaulagain Gandaki Medical College and Teaching Hospital, Pokhara, Nepal Author Pankaj Kumar Singh Nepalgunj Medical College and Teaching Hospital, Nepalgunj, Banke, Nepal Author Ravi Pandey Nepalgunj Medical College and Teaching Hospital, Nepalgunj, Banke, Nepal Author
dc.description.abstractAbstract: Introduction The majority of COVID patients with comorbidity were admitted to Intensive Care for treatment, and their outcomes were poor, necessitating the need for this study to determine the mortality due to comorbidities. This study aimed to find out the prevalence of comorbidities in COVID-19 mortality cases recorded in the tertiary hospital. Methods Cases with comorbidities among 162 cases of deaths due to COVID-19 were assessed in this retrospective cross-sectional study. Data were obtained from the Department of Biostatistics. Age, sex and comorbidity status were recorded in each mortality case. Ethical approval was obtained from the Institutional Review Committee. Results Out of 162 mortality cases, 62 (38.27%) patients had comorbidity. Among 62 mortality cases with ages ranging from 26-80 years and mean age was found to be 57.26 ± 11.18. Our data included a total of 41 (66.20%) males and 21 (33.80%) females. Diabetes with hypertension (23%) was the leading comorbidity in the COVID mortality case followed by hypertension (20%), diabetes (18%), chronic kidney disease (12%), hypothyroidism (9%), and other cases (18%). Other cases include upper gastrointestinal (UGI) bleeding, hepatic encephalopathy, old cerebrovascular accidents (CVA), liver abscess, and other surgical cases. Conclusion Diabetes with hypertension was the major comorbidity in COVID-19 mortality.
dc.identifierhttps://doi.org/10.59779/jiomnepal.1321
dc.identifier.urihttps://hdl.handle.net/20.500.14572/3091
dc.language.isoen_US
dc.publisherInstitute of Medicine, Tribhuvan University
dc.subjectComorbidity
dc.subjectCOVID
dc.subjectmortality
dc.subjectoutcome
dc.titleContribution of Comorbidities in Mortality of COVID-19 Patients Admitted to Tertiary Care Center: A Descriptive Cross-sectional Study
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage70
oaire.citation.startPage67
relation.isJournalIssueOfPublicationad0ee964-5350-4c0f-b399-39c51e2581f1
relation.isJournalIssueOfPublication.latestForDiscoveryad0ee964-5350-4c0f-b399-39c51e2581f1
relation.isJournalOfPublicationa9ba45d9-ee33-4a6b-b1fc-6626b87eec6c

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
67-70.pdf
Size:
323.06 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections